Dyadic International Inc. (DYAI) vs Lisata Therapeutics, Inc. (LSTA)
- Dyadic International Inc. DYAI 0.33 −5.71%
- Lisata Therapeutics, Inc. LSTA 1.21 −5.47%
Dyadic International Inc. and Lisata Therapeutics, Inc. are both Biotechnology companies. Dyadic International Inc. and Lisata Therapeutics, Inc. are of similar size ($14.0M and $13.8M). Dyadic International Inc. grew revenue faster over the last twelve months: −7.64% against −24.7%. Lisata Therapeutics, Inc. has the higher net margin (0.00% vs −226.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Lisata Therapeutics, Inc. leads on 8 and Dyadic International Inc. on 7.
Valuation
Profitability
| Metric | DYAI | LSTA | Biotechnology median |
|---|---|---|---|
| Gross margin | 17.85% | 0.49% | 67.24% |
| Operating margin | (237.12%) | 0.00% | 0.00% |
| Net margin | (226.87%) | 0.00% | 0.00% |
| Free cash flow margin | (227.93%) | 0.00% | 0.00% |
| Return on equity | (47,310.78%) | (101.66%) | (50.28%) |
| Return on assets | (71.43%) | (80.81%) | (45.89%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack